Oral mycophenolate mofetil immunosuppressant capsule, 250 mg per unit

This code represents the oral formulation of mycophenolate mofetil, an immunosuppressant medication. It is primarily used to prevent organ rejection in transplant recipients and to treat certain autoimmune diseases. The medication works by inhibiting the proliferation of lymphocytes, thereby suppressing the immune system.

This code is used when billing for the oral administration of mycophenolate mofetil, 250 mg strength, typically for patients undergoing solid organ transplantation (e.g., kidney, heart, liver) or those with autoimmune conditions like lupus nephritis. Documentation should clearly specify the drug, dosage, route of administration, and medical necessity for immunosuppression.

• Ensure the dosage billed (250 mg) aligns with the dispensed quantity. Multiple units may be billed if the prescribed dose exceeds 250 mg (e.g., 4 units for a 1000 mg dose).
• Distinguish this oral formulation from the intravenous (IV) formulation (J7518) and mycophenolic acid (J7519), which are distinct drugs with separate codes.
• Verify payer-specific policies regarding coverage for immunosuppressants, as some may require prior authorization or specific diagnostic codes.